...
首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
【24h】

A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

机译:BRCA1或BRCA2相关晚期卵巢上皮癌,输卵管癌或原发性腹膜癌患者Iniparib的2期单臂研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The aim of the study was to evaluate the activity and tolerability of iniparib monotherapy in women with BRCA1 or BRCA2-associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.
机译:目的:本研究的目的是评估iniparib单药治疗BRCA1或BRCA2相关的晚期上皮性卵巢癌,输卵管癌或原发性腹膜癌的活性和耐受性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号